Xconomy Seattle

Alder Biopharmaceuticals Inc. Receives $16,000,000 Series B Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7e86f7e2-c040-4aaa-bbb5-a3e886fdb978&Preview=1
Date
7/7/2006
Company Name
Alder Biopharmaceuticals Inc.
Mailing Address
11804 North Creek Parkway South Bothell, WA 98011
Company Description
Alder Biopharmaceuticals uniquely identifies, develops, and manufactures novel antibody therapeutics to alleviate human suffering in the autoimmune and inflammatory disease areas. Alder’s management team combines decades of industry experience with a proven track record for identifying and developing novel antibody therapeutics.
Website
http://www.alderbio.com
Transaction Type
Venture Equity
Transaction Amount
$16,000,000
Transaction Round
Series B
Proceeds Purposes
This additional funding represents another vote of confidence in Alder’s proprietary antibody technologies and therapeutic products.
M&A Terms
Venture Investor
H.I.G. Ventures
Venture Investor
Ventures West
Venture Investor
Sevin Rosen Funds